uep_logo
Strada delle Scotte, 6 53100 Siena
tel 0577 233228
info@insostanza.it

Sei in: InSostanza > Storie
storie #Nicotina

Cosa hanno fatto? Niente, continuano a fumare.

Fumare serenamente come se nulla fosse successo... va bene che di qualcosa si dovrà pur morire ma le sigarette sono un suicidio lento...

continua
storie #Nicotina

Ho bisogno di smettere di fumare.

Il mio vizio lavora contro tutti i miei sforzi di stabilire dei legami. La sigaretta li scinde e io, mio malgrado

continua
storie #Nicotina

Ho cominciato a farmi le canne prima delle sigarette

Ho cominciato a farmi le canne prima delle sigarette…le sigarette avrò cominciato [...]

continua
storie #Nicotina

Smettere di fumare

Una mattina aprendo la porta del bagno per farmi la doccia mi investì il panico all’idea di smettere di fumare

continua
storie #Nicotina

“Beve é diverso …”

io sono orfano di padre … a sedici anni. Quando ti succedono cose così cerchi ...

continua
storie #Nicotina

e-cigarettes e biblioteca

Forse ho capito perchè non esiste la droga perfetta.  Perchè comunque dopo un pò qualsiasi ...

continua

European Drug Report 2018: Trends and Developments.

High availability of drugs across all types. Over 1 million seizures in Europe in 2016. Over 92 million adults in the EU have tried an illicit drug in their lifetime. 1.3 million people received treatment for illicit drugs. Cocaine purity at street level reached its highest level in a decade. Increase in number of cocaine seizures. Increase in cocaine residues in wastewater in 26 of 31 cities between 2015 and 2017. Rise in number of first-time admissions to specialised treatment for problems related to cocaine. Europe is an important market for drugs trafficked in from other regions. But there are worrying signs of increased drug production inside Europe. Cannabis availability and use remain high. Cannabis is involved in 77 % of drug law offences. Rapid emergence of a commercial cannabis market in parts of the Americas. Fewer new psychoactive substances reported for the first time. But there is more evidence of harm. Health harms linked to highly potent new synthetic cannabinoids and synthetic opioids prompted nine risk assessments. Synthetic cannabinoids are the most frequently seized NPS in Europe. Synthetic opioids and particularly fentanyl derivatives are increasingly detected. Fentanyl derivatives — key players in the US opioid crisis — call for concern & vigilance. NPS use and related harms are a new challenge for prison system. Prisons are a critical setting for addressing the healthcare needs of drug users. Online markets appear to be of growing importance. A recent EMCDDA–Europol study identified more than 100 darknet markets. Concerns over unlicensed benzodiazepines sold on the street and online. Increasing number of overdose deaths raises concerns. Renewed focus on the role of take-home naloxone in overdose response strategies. Read more in the European Drug Report 2018: emcdda.europa.eu/edr2018

LE CREAZIONI DI INSOSTANZA